Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Élez E, Gómez-España MA, Grávalos C, García-Alfonso P, Ortiz-Morales MJ, Losa F, Díaz IA, Graña B, Toledano-Fonseca M, Valladares-Ayerbes M, Polo E, Salgado M, Martínez de Castro E, Safont MJ, Salud A, Ruiz-Casado A, Tabernero J, Riesco MDC, Rodriguez-Ariza A, Aranda E. Élez E, et al. Among authors: toledano fonseca m. Br J Cancer. 2022 Apr;126(6):874-880. doi: 10.1038/s41416-021-01638-w. Epub 2021 Dec 22. Br J Cancer. 2022. PMID: 34937947 Free PMC article. Clinical Trial.
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts.
Guil-Luna S, Mena R, Navarrete-Sirvent C, López-Sánchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Díaz C, Medina-Fernández FJ, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Guil-Luna S, et al. Front Med (Lausanne). 2020 Jul 3;7:264. doi: 10.3389/fmed.2020.00264. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32719800 Free PMC article.
Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells.
López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, Conde F, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. López-Sánchez LM, et al. Among authors: toledano fonseca m. Lab Invest. 2021 Mar;101(3):292-303. doi: 10.1038/s41374-020-00507-z. Epub 2020 Dec 1. Lab Invest. 2021. PMID: 33262438 Free article.
The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.
Toledano-Fonseca M, Cano MT, Inga E, Gómez-España A, Guil-Luna S, García-Ortiz MV, Mena-Osuna R, De la Haba-Rodriguez JR, Rodríguez-Ariza A, Aranda E. Toledano-Fonseca M, et al. Cancers (Basel). 2021 Mar 10;13(6):1210. doi: 10.3390/cancers13061210. Cancers (Basel). 2021. PMID: 33802006 Free PMC article.
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab.
Ortiz-Morales MJ, Toledano-Fonseca M, Mena-Osuna R, Cano MT, Gómez-España A, Haba-Rodríguez JR, Rodríguez-Ariza A, Aranda E. Ortiz-Morales MJ, et al. Among authors: toledano fonseca m. Cancers (Basel). 2022 Jun 21;14(13):3054. doi: 10.3390/cancers14133054. Cancers (Basel). 2022. PMID: 35804826 Free PMC article.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Toledano-Fonseca M, Gómez-España MA, Élez E, Grávalos C, García-Alfonso P, Rodríguez R, Losa F, Alés Díaz I, Graña B, Valladares-Ayerbes M, García-Ortiz MV, Polo E, Salgado M, Rivera F, Safont MJ, Salud A, Ruiz-Casado A, Tabernero JM, Riesco MC, Rodríguez-Ariza A, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Toledano-Fonseca M, et al. Biomed Pharmacother. 2023 Mar;159:114272. doi: 10.1016/j.biopha.2023.114272. Epub 2023 Jan 25. Biomed Pharmacother. 2023. PMID: 36706629 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 36775494
Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer.
Mena-Osuna R, Mantrana A, Guil-Luna S, Sánchez-Montero MT, Navarrete-Sirvent C, Morales-Ruiz T, Rivas-Crespo A, Toledano-Fonseca M, García-Ortíz MV, García-Jurado G, Gómez-España MA, González-Fernández R, Villar C, Medina-Fernández FJ, Villalba JM, Aranda E, Rodríguez-Ariza A. Mena-Osuna R, et al. Among authors: toledano fonseca m. J Pathol. 2023 Jul;260(3):261-275. doi: 10.1002/path.6080. Epub 2023 Apr 5. J Pathol. 2023. PMID: 37017456
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
García-Ortiz MV, Cano-Ramírez P, Toledano-Fonseca M, Cano MT, Inga-Saavedra E, Rodríguez-Alonso RM, Guil-Luna S, Gómez-España MA, Rodríguez-Ariza A, Aranda E. García-Ortiz MV, et al. Among authors: toledano fonseca m. Clin Epigenetics. 2023 Jul 22;15(1):118. doi: 10.1186/s13148-023-01535-4. Clin Epigenetics. 2023. PMID: 37481552 Free PMC article.
13 results